SERA PROGNOSTICS, INC. — Investor Relations & Filings

Sera Prognostics, Inc., also known as 'The Pregnancy Company®', is a health diagnostics company focused on improving maternal and infant health through precision pregnancy care. The company's flagship product is the PreTRM® Test, a first-of-its-kind biomarker blood test designed to predict the individual risk of spontaneous preterm birth in asymptomatic women with singleton pregnancies. The test is administered via a single blood draw during the 18th to 20th week of gestation, providing pivotal information to physicians for proactive management. Sera Prognostics also offers the LikeMine™ platform, which uses data from millions of pregnancies to offer comparative insights. The company aims to deliver high-value diagnostics to providers, mothers, payers, and employers to improve health outcomes and reduce healthcare costs associated with premature birth.